Given the complex roles of galectin-3, particularly in the epithelial-to-mesenchymal transition (EMT), and the variability in its expression reported in bladder urothelial carcinomas, this study seeks to elucidate several key aspects. Here, LGALS3 is linked to bladder transitional cell carcinoma.